Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '20 Dec 31, 2020	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Novel Gene and Cell Therapies, Biologics and Vaccines	4.05M
Novel Gene and Cell Therapies, Biologics and Vaccines Growth	-32.82%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '20 Dec 31, 2020	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States	4.05M
United States Growth	-32.82%